Results
2312
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,312 companies
Innoviva
Market Cap: US$1.2b
Engages in the development and commercialization of pharmaceutical products in the United States and internationally.
INVA
US$18.26
7D
-2.4%
1Y
13.3%
Pacira BioSciences
Market Cap: US$1.2b
Engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States.
PCRX
US$23.40
7D
-7.0%
1Y
-24.1%
Sienna Senior Living
Market Cap: CA$1.6b
Provides senior living services in Canada.
SIA
CA$17.57
7D
3.1%
1Y
18.6%
Amphastar Pharmaceuticals
Market Cap: US$1.1b
A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.
AMPH
US$23.88
7D
0.04%
1Y
-42.2%
89bio
Market Cap: US$1.1b
A clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases.
ETNB
US$7.80
7D
1.7%
1Y
-15.2%
BioLife Solutions
Market Cap: US$1.1b
Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.
BLFS
US$23.09
7D
5.2%
1Y
2.9%
Pulse Biosciences
Market Cap: US$1.1b
Operates as a novel bioelectric medicine company.
PLSE
US$16.84
7D
1.8%
1Y
119.0%
Natus Medical
Market Cap: US$1.1b
Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide.
NTUS
US$32.96
7D
0.8%
1Y
34.4%
Aveanna Healthcare Holdings
Market Cap: US$1.1b
A diversified home care platform company, provides pediatric and adult healthcare services in the United States.
AVAH
US$5.86
7D
22.3%
1Y
128.0%
BGM Group
Market Cap: US$1.1b
Through its subsidiaries, operates as a pharmaceutical and chemical company in China.
BGM
US$11.58
7D
5.4%
1Y
n/a
NeoGenomics
Market Cap: US$1.1b
Operates a network of cancer-focused testing laboratories in the United States and the United Kingdom.
NEO
US$8.36
7D
8.7%
1Y
-45.7%
Evolent Health
Market Cap: US$1.1b
Through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States.
EVH
US$9.27
7D
-10.4%
1Y
-61.1%
MiMedx Group
Market Cap: US$1.1b
Develops and distributes placental tissue allografts for various sectors of healthcare.
MDXG
US$7.17
7D
8.5%
1Y
-9.0%
Integra LifeSciences Holdings
Market Cap: US$1.1b
Manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology.
IART
US$13.51
7D
6.0%
1Y
-48.9%
Aurinia Pharmaceuticals
Market Cap: US$1.1b
A biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs.
AUPH
US$7.82
7D
-3.6%
1Y
47.3%
Spire Healthcare Group
Market Cap: UK£786.2m
Owns and operates private hospitals and clinics in the United Kingdom.
SPI
UK£1.95
7D
-3.7%
1Y
-24.7%
Viridian Therapeutics
Market Cap: US$1.0b
Engages in discovering, developing, and commercializing treatments for serious and rare diseases.
VRDN
US$12.81
7D
6.5%
1Y
-12.7%
Novavax
Market Cap: US$1.0b
A biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally.
NVAX
US$6.19
7D
2.0%
1Y
-54.1%
Nika Pharmaceuticals
Market Cap: US$1.0b
Engages in the development and distribution of various pharmaceutical products.
NIKA
US$1.00
7D
0%
1Y
42.9%
Pennant Group
Market Cap: US$1.0b
Provides healthcare services in the United States.
PNTG
US$29.17
7D
8.7%
1Y
31.3%
InMode
Market Cap: US$1.0b
Designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally.
INMD
US$14.92
7D
4.3%
1Y
-19.7%
Wave Life Sciences
Market Cap: US$1.0b
A clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform.
WVE
US$6.39
7D
-0.3%
1Y
9.4%
Gyre Therapeutics
Market Cap: US$1.0b
A pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis.
GYRE
US$11.50
7D
29.9%
1Y
-26.4%
STAAR Surgical
Market Cap: US$1.0b
Designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye.
STAA
US$19.00
7D
1.9%
1Y
-56.5%
Establishment Labs Holdings
Market Cap: US$1.0b
A medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries.
ESTA
US$34.96
7D
5.9%
1Y
-40.6%
OPKO Health
Market Cap: US$999.2m
A healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally.
OPK
US$1.30
7D
1.6%
1Y
-0.4%
Neuren Pharmaceuticals
Market Cap: AU$1.5b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$13.18
7D
4.4%
1Y
-38.2%
Phibro Animal Health
Market Cap: US$993.1m
Operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally.
PAHC
US$24.60
7D
29.2%
1Y
35.1%
Mineralys Therapeutics
Market Cap: US$985.5m
A clinical-stage biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States.
MLYS
US$15.19
7D
2.9%
1Y
16.2%
Harrow
Market Cap: US$978.4m
An eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products.
HROW
US$26.27
7D
8.9%
1Y
61.8%
Nanosonics
Market Cap: AU$1.5b
Operates as an infection prevention company globally.
NAN
AU$4.69
7D
-3.5%
1Y
61.7%
Collegium Pharmaceutical
Market Cap: US$957.8m
A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.
COLL
US$29.80
7D
10.2%
1Y
-10.5%
Syndax Pharmaceuticals
Market Cap: US$945.7m
A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.
SNDX
US$10.19
7D
-4.2%
1Y
-53.0%
Enliven Therapeutics
Market Cap: US$932.7m
A clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer.
ELVN
US$20.03
7D
1.7%
1Y
-16.1%
Oculis Holding
Market Cap: US$931.8m
A clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases in Switzerland, Iceland, and internationally.
OCS
US$17.76
7D
-3.0%
1Y
46.1%
Arcus Biosciences
Market Cap: US$931.8m
A clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States.
RCUS
US$8.67
7D
6.8%
1Y
-49.3%